title: Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats.
abstract: Effects of the water extract of Centella asiatica Linn. on formation of azoxymethane (AOM)-induced aberrant crypt foci (ACF) and intestinal tumorigenesis in male F344 rats were investigated. Treatment with the extract significantly decreased the number of larger ACF (with four or more crypts per focus) in the large intestine in the early stage, while the number of methylated DNA adducts was not decreased compared with that in the AOM-treated group. In the post-initiation stage, the extract significantly decreased the total number of ACF and the number of larger ACF, accompanied by a decrease in the 5-bromo-2'-deoxyuridine-labeling index and an increase in the induction of apoptotic cells in the colonic mucosa. The incidences of neoplasms, the numbers of adenocarcinomas in the small intestines and entire intestines, and sizes of neoplasms in the entire intestines in rats fed C. asiatica extract at a dose of 10 mg/kg were smaller than those in rats given AOM alone (p < 0.05). The extract at a dose of 100 mg/kg significantly reduced the multiplicity of neoplasms in the small intestine (p < 0.05). These results suggest that inhibition of the formation of AOM-induced ACF by C. asiatica extract is associated with modification of cell proliferation and induction of apoptosis in colonic crypts and that the extract has a chemopreventive effect on colon tumorigenesis.
authors.affiliation: Department of Molecular Bacteriology, Graduate School of Medicine, The University of Tokushima, Tokushima 770-8503, Japan.
authors.forename: P
authors.initials: P
authors.lastname: Bunpo
authors.forename: K
authors.initials: K
authors.lastname: Kataoka
authors.forename: H
authors.initials: H
authors.lastname: Arimochi
authors.forename: H
authors.initials: H
authors.lastname: Nakayama
authors.forename: T
authors.initials: T
authors.lastname: Kuwahara
authors.forename: Y
authors.initials: Y
authors.lastname: Bando
authors.forename: K
authors.initials: K
authors.lastname: Izumi
authors.forename: U
authors.initials: U
authors.lastname: Vinitketkumnuen
authors.forename: Y
authors.initials: Y
authors.lastname: Ohnishi
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents; D000963:Antimetabolites; D017209:Apoptosis / Q000187:drug effects; D001397:Azoxymethane / Q000037:antagonists & inhibitors* / Q000633:toxicity*; D001973:Bromodeoxyuridine; D002273:Carcinogens / Q000633:toxicity*; D049109:Cell Proliferation / Q000187:drug effects; D028041:Centella / Q000737:chemistry*; D003106:Colon / Q000187:drug effects / Q000378:metabolism; D019175:DNA Methylation / Q000187:drug effects; D004032:Diet; D006147:Guanine / Q000031:analogs & derivatives* / Q000378:metabolism; D007413:Intestinal Mucosa / Q000166:cytology / Q000187:drug effects; D007414:Intestinal Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010936:Plant Extracts / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D016588:Anticarcinogenic Agents; D000963:Antimetabolites; D002273:Carcinogens; D010936:Plant Extracts; D006147:Guanine; C008449:O-(6)-methylguanine; D001973:Bromodeoxyuridine; D001397:Azoxymethane